Nov 24th, 2025

Novo’s Ozempic Pill Fails to Slow Alzheimer’s in Studies

A pill version of Novo Nordisk’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of trials. Naomi Kresge reports on Bloomberg Television